The Wnt Signalling Pathway: A Tailored Target in Cancer

Int J Mol Sci. 2020 Oct 18;21(20):7697. doi: 10.3390/ijms21207697.

Abstract

Cancer is one of the greatest public health challenges. According to the World Health Organization (WHO), 9.6 million cancer deaths have been reported in 2018. The most common cancers include lung, breast, colorectal, prostate, skin (non-melanoma) and stomach cancer. The unbalance of physiological signalling pathways due to the acquisition of mutations in tumour cells is considered the most common cancer driver. The Wingless-related integration site (Wnt)/β-catenin pathway is crucial for tissue development and homeostasis in all animal species and its dysregulation is one of the most relevant events linked to cancer development and dissemination. The canonical and the non-canonical Wnt/β-catenin pathways are known to control both physiological and pathological processes, including cancer. Herein, the impact of the Wnt/β-catenin cascade in driving cancers from different origin has been examined. Finally, based on the impact of Extracellular Vesicles (EVs) on tumour growth, invasion and chemoresistance, and their role as tumour diagnostic and prognostic tools, an overview of the current knowledge linking EVs to the Wnt/β-catenin pathway is also discussed.

Keywords: Wnt/β-catenin dependent pathway; Wnt/β-catenin independent pathway; breast cancer; colorectal cancer; extracellular vesicles; ovarian cancer.

Publication types

  • Review

MeSH terms

  • Animals
  • Cell Polarity
  • Extracellular Vesicles / metabolism
  • Humans
  • MicroRNAs / genetics
  • MicroRNAs / metabolism
  • Molecular Targeted Therapy*
  • Neoplasms / genetics
  • Neoplasms / metabolism*
  • Neoplasms / therapy*
  • Wnt Signaling Pathway*

Substances

  • MicroRNAs